4th Quarter - Report — GOLDBUG STRATEGIES LLC for GENOMIC HEALTH INC. (2012)

Firm

GOLDBUG STRATEGIES LLC

Client

GENOMIC HEALTH INC.

Income

$20,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207

Lobbyist	Covered position, as disclosed
SHEILA D WALCOFF	Committee, US House Of Representatives

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 3207 (112th)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207

Lobbyist	Covered position, as disclosed
SHEILA D WALCOFF	Committee, US House Of Representatives

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 3207 (112th)

Health Issues HCR

FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207

Lobbyist	Covered position, as disclosed
SHEILA D WALCOFF	Committee, US House Of Representatives

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.